DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene ...

AlphaGenome is a DNA sequence model that advances regulatory variant-effect prediction to understand genome function.

The model’s release comes five years after DeepMind introduced its seminal AlphaFold neural network. The latter algorithm can ...

Last month, Demis Hassabis and John Jumper of Google DeepMind were jointly awarded the 2024 Nobel Prize in Chemistry for their development of AlphaFold 3. This AI model can more accurately predict the ...

The artificial intelligence–based structure-prediction software AlphaFold, originally developed by Google DeepMind, has quickly become an important tool for drug discovery. Its original iteration ...

Model predicts effect of mutations on sequences up to 1 million base pairs in length and is adept at tackling complex ...

Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...

The AI tool AlphaFold has been improved so that it can now predict the shape of very large and complex protein structures. Linköping University researchers have also succeeded in integrating ...

Once disregarded as “junk DNA,” scientists now know that this molecular dark matter is crucial for determining gene activity ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...